Asia-Pacific Pharma Ophthalmic Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Pharma Ophthalmic Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Retinal disorders drugs Market Performance (Volume)
  • 2.1.2 Allergic, inflammatory and infective drugs Market Performance (Volume)
  • 2.1.3 Glaucoma drugs Market Performance (Volume)
  • 2.1.4 Dry eye drugs Market Performance (Volume)
  • 2.1.5 Other ophthalmic drugs Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Retinal disorders drugs Market Performance (Value)
  • 2.1.2 Allergic, inflammatory and infective drugs Market Performance (Value)
  • 2.1.3 Glaucoma drugs Market Performance (Value)
  • 2.1.4 Dry eye drugs Market Performance (Value)
  • 2.1.5 Other ophthalmic drugs Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Glaucoma Market Performance (Volume)
  • 3.1.2 Dry eye syndrome Market Performance (Volume)
  • 3.1.3 Retinal diseases Market Performance (Volume)
  • 3.1.4 Other ophthalmic indications Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Novartis
  • 4.1.1 Novartis Profiles
  • 4.1.2 Novartis Product Information
  • 4.1.3 Novartis Pharma Ophthalmic Business Performance
  • 4.1.4 Novartis Pharma Ophthalmic Business Development and Market Status
• 4.2 Allergan
  • 4.2.1 Allergan Profiles
  • 4.2.2 Allergan Product Information
  • 4.2.3 Allergan Pharma Ophthalmic Business Performance
  • 4.2.4 Allergan Pharma Ophthalmic Business Development and Market Status
• 4.3 Roche
  • 4.3.1 Roche Profiles
  • 4.3.2 Roche Product Information
  • 4.3.3 Roche Pharma Ophthalmic Business Performance
  • 4.3.4 Roche Pharma Ophthalmic Business Development and Market Status
• 4.4 Valeant
  • 4.4.1 Valeant Profiles
  • 4.4.2 Valeant Product Information
  • 4.4.3 Valeant Pharma Ophthalmic Business Performance
  • 4.4.4 Valeant Pharma Ophthalmic Business Development and Market Status
• 4.5 Regeneron
  • 4.5.1 Regeneron Profiles
  • 4.5.2 Regeneron Product Information
  • 4.5.3 Regeneron Pharma Ophthalmic Business Performance
  • 4.5.4 Regeneron Pharma Ophthalmic Business Development and Market Status
• 4.6 Santen
  • 4.6.1 Santen Profiles
  • 4.6.2 Santen Product Information
  • 4.6.3 Santen Pharma Ophthalmic Business Performance
  • 4.6.4 Santen Pharma Ophthalmic Business Development and Market Status
• 4.7 Bayer
  • 4.7.1 Bayer Profiles
  • 4.7.2 Bayer Product Information
  • 4.7.3 Bayer Pharma Ophthalmic Business Performance
  • 4.7.4 Bayer Pharma Ophthalmic Business Development and Market Status
• 4.8 Pfizer
  • 4.8.1 Pfizer Profiles
  • 4.8.2 Pfizer Product Information
  • 4.8.3 Pfizer Pharma Ophthalmic Business Performance
  • 4.8.4 Pfizer Pharma Ophthalmic Business Development and Market Status
• 4.9 Senju
  • 4.9.1 Senju Profiles
  • 4.9.2 Senju Product Information
  • 4.9.3 Senju Pharma Ophthalmic Business Performance
  • 4.9.4 Senju Pharma Ophthalmic Business Development and Market Status
• 4.10 Akorn
  • 4.10.1 Akorn Profiles
  • 4.10.2 Akorn Product Information
  • 4.10.3 Akorn Pharma Ophthalmic Business Performance
  • 4.10.4 Akorn Pharma Ophthalmic Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Asia-Pacific Pharma Ophthalmic Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Asia-Pacific Pharma Ophthalmic Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Asia-Pacific Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Asia-Pacific Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Japan Market Performance for Manufacturers
  • 6.2.1 Japan Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Japan Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Japan Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Japan Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Korea Market Performance for Manufacturers
  • 6.3.1 South Korea Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Korea Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Korea Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Korea Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Taiwan Market Performance for Manufacturers
  • 6.4.1 Taiwan Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Taiwan Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Taiwan Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Taiwan Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 India Market Performance for Manufacturers
  • 6.5.1 India Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 India Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 India Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 India Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Southeast Asia Market Performance for Manufacturers
  • 6.6.1 Southeast Asia Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Southeast Asia Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Southeast Asia Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Southeast Asia Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Australia Market Performance for Manufacturers
  • 6.7.1 Australia Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Australia Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Australia Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Australia Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Asia-Pacific Pharma Ophthalmic Market Performance (Sales Point)

• 7.1 Asia-Pacific Pharma Ophthalmic Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Asia-Pacific Pharma Ophthalmic Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Asia-Pacific Pharma Ophthalmic Price (USD/Unit) by Regions 2013-2018
• 7.4 Asia-Pacific Pharma Ophthalmic Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Asia-Pacific Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Japan Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Korea Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Taiwan Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 India Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Southeast Asia Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Glaucoma Industry
• 11.2 Dry eye syndrome Industry
• 11.3 Retinal diseases Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Asia-Pacific Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Asia-Pacific Pharma Ophthalmic Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Japan Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Korea Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Taiwan Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 India Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Southeast Asia Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Australia Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Retinal disorders drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Allergic, inflammatory and infective drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Glaucoma drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.5 Dry eye drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Glaucoma Sales and and Growth Rate 2019-2024
  • 12.4.3 Dry eye syndrome Sales and and Growth Rate 2019-2024
  • 12.4.4 Retinal diseases Sales and and Growth Rate 2019-2024
  • 12.4.5 Other ophthalmic indications Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Asia-Pacific Pharma Ophthalmic Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Asia-Pacific Pharma Ophthalmic Gross Profit Trend 2019-2024

13 Conclusion